WallStSmart

Amrize Ltd (AMRZ)vsCRH PLC ADR (CRH)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

CRH PLC ADR generates 224% more annual revenue ($38.63B vs $11.91B). CRH leads profitability with a 9.9% profit margin vs 9.7%. AMRZ appears more attractively valued with a PEG of 1.37. CRH earns a higher WallStSmart Score of 65/100 (C+).

AMRZ

Hold

49

out of 100

Grade: D+

Growth: 4.0Profit: 5.0Value: 5.7Quality: 5.0
Piotroski: 2/9Altman Z: 1.61

CRH

Buy

65

out of 100

Grade: C+

Growth: 6.0Profit: 7.0Value: 4.7Quality: 6.5
Piotroski: 4/9Altman Z: 2.16
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for AMRZ.

CRHSignificantly Overvalued (-68.2%)

Margin of Safety

-68.2%

Fair Value

$59.45

Current Price

$100.48

$41.03 premium

UndervaluedFair: $59.45Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

AMRZ1 strengths · Avg: 8.0/10
Price/BookValuation
2.0x8/10

Reasonable price relative to book value

CRH4 strengths · Avg: 8.5/10
Market CapQuality
$65.76B9/10

Large-cap with strong market position

Return on EquityProfitability
21.9%9/10

Every $100 of equity generates 22 in profit

P/E RatioValuation
17.4x8/10

Attractively priced relative to earnings

Price/BookValuation
2.8x8/10

Reasonable price relative to book value

Areas to Watch

AMRZ4 concerns · Avg: 3.8/10
Revenue GrowthGrowth
4.7%4/10

4.7% revenue growth

EPS GrowthGrowth
3.6%4/10

3.6% earnings growth

Altman Z-ScoreHealth
1.614/10

Distress zone — elevated risk

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

CRH2 concerns · Avg: 3.0/10
PEG RatioValuation
1.904/10

Expensive relative to growth rate

Free Cash FlowQuality
$-1.22B2/10

Negative free cash flow — burning cash

Comparative Analysis Report

WallStSmart Research

Bull Case : AMRZ

The strongest argument for AMRZ centers on Price/Book. PEG of 1.37 suggests the stock is reasonably priced for its growth.

Bull Case : CRH

The strongest argument for CRH centers on Market Cap, Return on Equity, P/E Ratio.

Bear Case : AMRZ

The primary concerns for AMRZ are Revenue Growth, EPS Growth, Altman Z-Score.

Bear Case : CRH

The primary concerns for CRH are PEG Ratio, Free Cash Flow.

Key Dynamics to Monitor

CRH is growing revenue faster at 5.6% — sustainability is the question.

AMRZ generates stronger free cash flow (-1.2B), providing more financial flexibility.

Monitor BUILDING MATERIALS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

CRH scores higher overall (65/100 vs 49/100). Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Amrize Ltd

BASIC MATERIALS · BUILDING MATERIALS · USA

Amrize Ltd (AMRZ) is an innovative technology firm at the forefront of the digital health and wellness industry, dedicated to transforming healthcare delivery with cutting-edge technologies and data-driven solutions. The company prioritizes enhancing patient outcomes and access to care, significantly investing in research and development to address the rising demand for scalable health innovations. With a diverse portfolio of products and strategic initiatives, Amrize is well-positioned to become a critical player in the ongoing evolution of healthcare, presenting a compelling investment opportunity for institutional investors navigating a dynamic market.

Visit Website →

CRH PLC ADR

BASIC MATERIALS · BUILDING MATERIALS · USA

CRH plc manufactures and distributes construction materials. The company is headquartered in Dublin, Ireland.

Visit Website →

Want to dig deeper into these stocks?